Hormonal
Subcutaneous semaglutide at 2.4 mg once weekly produces clinically significant weight loss (mean 14.9–17.4% reduction) in adults with obesity or overweight, with gastrointestinal side effects being the primary limiting factor.
For adults with obesity, weekly subcutaneous semaglutide (2.4 mg) combined with lifestyle changes leads to substantial weight loss (approx. 15%). The main barrier is gastrointestinal side effects like nausea, which are usually mild and do not prevent weight loss. If injections are not preferred, oral semaglutide is an alternative, though subcutaneous administration may yield slightly greater weight loss.
Results showed that semaglutide combined with lifestyle modification leads to clinically significant weight loss in patients with obesity compared to placebo... In all STEP studies, subcutaneous administration of semaglutide at a dose of 2.4 mg once weekly consistently resulted in an average weight loss of 14.9–17.4% in participants without DM2...
Why this rating
Based on multiple Phase 3 randomized controlled trials (STEP 1-5) with large sample sizes.
Source
Semaglutide — effectiveness in weight loss and side effects when used according to studies by SUSTAIN, PIONEER, STEP
O. R. Shabutdinova et al. · Problems of Endocrinology · 2023
DOI 10.14341/probl13197
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →